Sangamo Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OTC.Pink
Sangamo Therapeutics is holding its annual stockholder meeting to vote on director elections, executive compensation, and an amendment to its equity incentive plan.
OTC.Pink
Sangamo Therapeutics is holding its 2024 Annual Meeting of Stockholders on June 4, 2024, to vote on key proposals including the election of directors, executive compensation, equity incentive plan amendments, and an increase in authorized shares.